Literature DB >> 27888220

Castleman's disease in carcinoma gall bladder.

Vijay Waman Dhakre1, Sanjay Nagral2,3, Aditya Jayesh Nanavati3.   

Abstract

Castleman's disease (CD) also known as angiofollicular lymph node hyperplasia represents a group of uncommon non-clonal lymphoproliferation. We herein report a case of CD associated with carcinoma of the gall bladder. To the best of our knowledge, it is the first of its kind and has not been reported in the past. The hypothesis regarding the aetiopathogenesis of CD is that it is associated with interleukin-6 surges. This may be explained by the overproduction of IL-6 by tumour cells or IL-6 production due to a long-standing/smouldering localised inflammatory response. An important question raised by this observation is whether the finding of CD has any effect on the outcome of this patient of carcinoma of the gall bladder. Further research is required in this matter. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27888220      PMCID: PMC5174778          DOI: 10.1136/bcr-2016-217325

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

2.  Castleman disease imitating pancreatic tumor presenting with pericardial and pleural effusion.

Authors:  Justyna Wasielica-Berger; Magdalena Kaniewska; Dariusz Cepowicz; Urszula Wereszczynska-Siemiatkowska; Boguslaw Kedra; Andrzej Dabrowski
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

Review 3.  Castleman's disease: systematic analysis of 416 patients from the literature.

Authors:  Nadia Talat; Klaus-Martin Schulte
Journal:  Oncologist       Date:  2011-07-17

4.  Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.

Authors:  Aisheng Dong; Hui Dong; Changjing Zuo
Journal:  Clin Nucl Med       Date:  2014-01       Impact factor: 7.794

5.  Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.

Authors:  Frits van Rhee; Katie Stone; Susann Szmania; Bart Barlogie; Zeba Singh
Journal:  Clin Adv Hematol Oncol       Date:  2010-07

Review 6.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

Review 7.  Multicentric Castleman's disease in HIV infection: a systematic review of the literature.

Authors:  Eleni E Mylona; Ioannis G Baraboutis; Lazaros J Lekakis; Ourania Georgiou; Vasilios Papastamopoulos; Athanasios Skoutelis
Journal:  AIDS Rev       Date:  2008 Jan-Mar       Impact factor: 2.500

Review 8.  HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Authors:  David C Fajgenbaum; Frits van Rhee; Christopher S Nabel
Journal:  Blood       Date:  2014-03-12       Impact factor: 22.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.